ArticleVaccines2022

Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms.

Diego Cantoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.